However, treatment with a PKC-β inhibitor rescued 95% of the VEGF-induced increase in vascular permeability, indicating that PKC-β plays a major role in VEGF-induced hyperpermeability in diabetic retinopathy (90, 91). This evidence concerns the gene PRKCB and diabetic retinopathy.